2022
DOI: 10.3390/antiox11030525
|View full text |Cite
|
Sign up to set email alerts
|

Ginkgo biloba in the Aging Process: A Narrative Review

Abstract: Neurodegenerative diseases, cardiovascular disease (CVD), hypertension, insulin resistance, cancer, and other degenerative processes commonly appear with aging. Ginkgo biloba (GB) is associated with several health benefits, including memory and cognitive improvement, in Alzheimer’s disease (AD), Parkinson’s disease (PD), and cancer. Its antiapoptotic, antioxidant, and anti-inflammatory actions have effects on cognition and other conditions associated with aging-related processes, such as insulin resistance, hy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
37
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 51 publications
(44 citation statements)
references
References 141 publications
0
37
0
Order By: Relevance
“…Commercialized GBE, EGB 761 ® , has a recognized neuroprotective role for cognitive impairment like Alzheimer's disease (AD) (Liu et al, 2019;Verma et al, 2020;Abdelmeguid et al, 2021;Ge et al, 2021;Zhao et al, 2021). In many European states, EGB 761 ® is the only drug therapy in the guideline for treating mild cognitive impairment (MCI) Frontiers in Pharmacology frontiersin.org (Kandiah et al, 2019;Tomino et al, 2021;Barbalho et al, 2022).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Commercialized GBE, EGB 761 ® , has a recognized neuroprotective role for cognitive impairment like Alzheimer's disease (AD) (Liu et al, 2019;Verma et al, 2020;Abdelmeguid et al, 2021;Ge et al, 2021;Zhao et al, 2021). In many European states, EGB 761 ® is the only drug therapy in the guideline for treating mild cognitive impairment (MCI) Frontiers in Pharmacology frontiersin.org (Kandiah et al, 2019;Tomino et al, 2021;Barbalho et al, 2022).…”
Section: Discussionmentioning
confidence: 99%
“…Commercialized GBE, EGB 761 ® , has a recognized neuroprotective role for cognitive impairment like Alzheimer’s disease (AD) ( Liu et al, 2019 ; Verma et al, 2020 ; Abdelmeguid et al, 2021 ; Ge et al, 2021 ; Zhao et al, 2021 ). In many European states, EGB 761®is the only drug therapy in the guideline for treating mild cognitive impairment (MCI) ( Kandiah et al, 2019 ; Tomino et al, 2021 ; Barbalho et al, 2022 ). Various studies have provided experimental evidence supporting GBE, a mixture of active components, as a competent intervention for alleviating PD ( Kuang et al, 2018 ; Mohammed et al, 2020 ; Yu et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…The use of ginkgo for the treatment of neurodegenerative diseases is widely recognized [ 15 ]. As described by Uddin et al [ 108 ], biflavonoids are molecules that have the potential to noticeably alter the aggregation of tau and Aβ and efficiently reduce the toxic effect of Aβ-oligomers compared to monoflavonoids.…”
Section: Biological Activity Of Ginkgobiflavonoidsmentioning
confidence: 99%
“…In traditional Chinese medicine, leaves and fruits have been used for several centuries with documented use dating back from 1280 to 1368 AD and the use of ginkgo nuts mentioned as early as the Yuan Dynasty [ 13 ]. For more than 500 years, various medicinal properties have been attributed to the nuts, including melioration of asthma, cough, and bladder infections, while leaves have been used mainly to treat skin infections and pulmonary dysfunction (reviewed by [ 14 , 15 ]). Although it is well used in Chinese medicine, the true value of this 200-million-year-old plant species was recognized only 40 years ago.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation